Stephane de Botton

Stephane de Botton

UNVERIFIED PROFILE

Are you Stephane de Botton?   Register this Author

Register author
Stephane de Botton

Stephane de Botton

Publications by authors named "Stephane de Botton"

Are you Stephane de Botton?   Register this Author

94Publications

4342Reads

45Profile Views

5-Azacitidine in Patients with IDH1/2-mutant Recurrent Glioma.

Neuro Oncol 2020 Mar 26. Epub 2020 Mar 26.

Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/noaa074DOI Listing
March 2020

Spontaneous molecular response of IDH2 acute myeloid leukemia.

Ann Hematol 2020 Feb 9;99(2):353-354. Epub 2019 Dec 9.

Département d'Hématologie, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-019-03876-8DOI Listing
February 2020

Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.

N Engl J Med 2018 Jun 2;378(25):2386-2398. Epub 2018 Jun 2.

From the University of Texas M.D. Anderson Cancer Center, Houston (C.D.D., H.M.K.); Memorial Sloan Kettering Cancer Center (E.M.S., M.S.T.) and Weill Cornell Medical College (G.J.R.), New York; Institut Gustave Roussy, Villejuif (S.B., C.W.), and Centre Hospitalier Universitaire Bordeaux, Bordeaux (A.P.) - both in France; Northwestern University, Chicago (J.K.A.); Ohio State University Wexner Medical Center, Columbus (A.S.M.); Sylvester Comprehensive Cancer Center, University of Miami, Miami (R.S.); University of Texas Southwestern Medical Center, Dallas (R.H.C.); University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco (G.N.M.), and City of Hope Medical Center, Duarte (A.S.S.) - both in California; University of Colorado School of Medicine, Aurora (D.A.P.); Sarah Cannon Research Institute, Nashville (W.D.); Massachusetts General Hospital Cancer Center (A.T.F.) and Dana-Farber Cancer Institute (R.M.S.), Boston, and Agios Pharmaceuticals, Cambridge (S.C., H.W., V.Z., K.E.Y., S.M.K., H.Y., D.D., B.F., M.G., H.L., S.A., B.W., E.C.A.) - all in Massachusetts; University of Alabama at Birmingham, Birmingham (H.P.E.); Johns Hopkins University, Baltimore (G.T.P.); Washington University School of Medicine, St. Louis (G.L.U.); Mayo Clinic, Jacksonville, FL (J.M.F.); Oregon Health and Science University Knight Cancer Institute, Portland (E.T.); Hollings Cancer Center, Medical University of South Carolina, Charleston (R.K.S.); Winship Cancer Institute of Emory University, Atlanta (M.L.A.); Mayo Clinic, Phoenix, AZ (J.L.S.); and Cleveland Clinic, Cleveland (M.A.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1716984DOI Listing
June 2018

Randomized Phase II Study of Clofarabine-Based Consolidation for Younger Adults With Acute Myeloid Leukemia in First Remission.

J Clin Oncol 2017 Apr 21;35(11):1223-1230. Epub 2017 Feb 21.

Xavier Thomas, Lyon-Sud University Hospital, Pierre Bénite; Stéphane de Botton, Gustave-Roussy Cancer Institute, Villejuif; Sylvie Chevret, Emmanuel Raffoux, and Hervé Dombret, Paris Saint-Louis University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), University Paris Diderot; Olivier Hermine, Paris Necker University Hospital, AP-HP, University Paris Descartes; Karine Celli-Lebras, Acute Leukemia French Association Coordination Office, Paris Saint-Louis University Hospital, Paris; Denis Caillot, Dijon University Hospital, Dijon; Emilie Lemasle, Henri-Becquerel Cancer Center, Rouen; Jean-Pierre Marolleau, Amiens University Hospital, Amiens; Céline Berthon, Claude Huriez University Hospital; Claude Preudhomme, University of Lille, Claude Huriez University Hospital, Institut National de la Santé et de la Recherche Médicale UMR-S 1172, Jean-Pierre Aubert Research Institute, Lille; Arnaud Pigneux, Bordeaux Haut-Leveque University Hospital, Pessac; Norbert Vey, Paoli-Calmette Cancer Institute, Marseille; Oumedaly Reman, George-Clémenceau University Hospital, Caen; Marc Simon, Valenciennes Hospital, Valenciennes; Christian Recher, Toulouse Cancer University Institute, Toulouse; Jean-Yves Cahn, Grenoble University Hospital, Grenoble; Sylvie Castaigne and Christine Terré, Versailles University Hospital, Versailles-Saint Quentin University, Le Chesnay; and Norbert Ifrah, Angers University Hospital, Angers, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.4551DOI Listing
April 2017

Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With NPM1 Mutation: A Study by the Acute Leukemia French Association Group.

J Clin Oncol 2017 Jan 14;35(2):185-193. Epub 2016 Nov 14.

Marie Balsat, Xavier Thomas, and Sandrine Hayette, Centre Hospitalier Lyon Sud, Pierre Benite; Aline Renneville, Alice Marceau, Olivier Nibourel, Céline Rodriguez, and Claude Preudhomme, CHRU of Lille; Aline Renneville, Alice Marceau, Olivier Nibourel, and Claude Preudhomme, Cancer Research Institute of Lille and Université Lille; and Céline Berthon, Claude Huriez Hospital, Lille; Stéphane de Botton, Institut Gustave Roussy, Villejuif; Denis Caillot, Dijon University Hospital, Dijon; Emilie Lemasle, Henri-Becquerel Center, Rouen; Jean-Pierre Marolleau, Amiens University Hospital, Amiens; Emmanuel Raffoux, Hervé Dombret, Jean-Michel Cayuela, Marie Magdeleine Coudé, Karine Celli-Lebras, and Nicolas Boissel, Hôpital Saint-Louis, AP-HP; Emmanuel Raffoux, Herve Dombret, and Nicolas Boissel, University 7 Paris Diderot; and Thorsten Braun, Hôpital Avicennes, AP-HP, Paris; Arnaud Pigneux, Haut-Leveque Hospital, Pessac; Norbert Vey, Paoli-Calmette Institute, Marseille; and Christine Terre, Hôpital de Versailles, Le Chesnay, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.1875DOI Listing
January 2017

IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives.

J Blood Med 2016 2;7:171-80. Epub 2016 Sep 2.

Gustave Roussy, Université Paris-Saclay, Service d'Hématologie Clinique; INSERM U1170, Gustave Roussy, Université Paris-Saclay, Villejuif; Faculté de médecine Paris-Sud, Kremlin-Bicêtre.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/JBM.S70716DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015873PMC
September 2016

Quantitation of isocitrate dehydrogenase (IDH)-induced D and L enantiomers of 2-hydroxyglutaric acid in biological fluids by a fully validated liquid tandem mass spectrometry method, suitable for clinical applications.

J Chromatogr B Analyt Technol Biomed Life Sci 2016 Jun 23;1022:290-297. Epub 2016 Apr 23.

Gustave Roussy Cancer Campus Grand Paris, Service de Pharmacologie, Département de Biologie et Pathologie Médicales, Villejuif 94805, France; Université Paris-Sud, Laboratoire de Vectorologie et Thérapeutiques Anticancéreuses, UMR 8203, Villejuif 94805, France; Centre National de la Recherche Scientifique (CNRS), Laboratoire de Vectorologie et Thérapeutiques Anticancéreuses, UMR 8203, Villejuif 94805, France; Gustave Roussy Cancer Campus Grand Paris, Laboratoire de Vectorologie et Thérapeutiques Anticancéreuses, UMR 8203, Villejuif 94805, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchromb.2016.04.030DOI Listing
June 2016

Hyperferritinemia at diagnosis predicts relapse and overall survival in younger AML patients with intermediate-risk cytogenetics.

Leuk Res 2015 Aug 14;39(8):818-21. Epub 2015 May 14.

Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France; Université Toulouse III Paul Sabatier, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01452126150013
Publisher Site
http://dx.doi.org/10.1016/j.leukres.2015.05.001DOI Listing
August 2015

Myeloid sarcoma of the nasopharynx mimicking an aggressive lymphoma.

Head Neck Pathol 2014 Jun 8;8(2):234-8. Epub 2013 Oct 8.

Clinical Haematology Department, Institut Gustave Roussy (IGR), 114 rue Edouard Vaillant, 94805, Villejuif, France,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12105-013-0495-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022928PMC
June 2014

Serum 2-hydroxyglutarate production in IDH1- and IDH2-mutated de novo acute myeloid leukemia: a study by the Acute Leukemia French Association group.

J Clin Oncol 2014 Feb 16;32(4):297-305. Epub 2013 Dec 16.

Maxime Janin, Robert Barouki, Daniel Rabier, and Chris Ottolenghi, Biochimie Métabolique, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Necker-Enfants Malades; Maxime Janin, Robert Barouki, and Chris Ottolenghi, Institut National de la Santé et de la Recherche Médicale (INSERM) U747, Université Paris Descartes; Hervé Dombret, Hôpital Saint-Louis, Paris; Elena Mylonas, Cyril Quivoron, Laurianne Scourzic, Olivier Adrien Bernard, Virginie Penard-Lacronique, and Stéphane de Botton, INSERM U985, Institut Gustave Roussy; Elena Mylonas, Cyril Quivoron, Laurianne Scourzic, Eric Solary, Olivier Adrien Bernard, and Virginie Penard-Lacronique, Institut Fédératif de Recherche 54, Institut Gustave Roussy; Véronique Saada, Sébastien Forget, Nathalie Auger, Frank Griscelli, Elisabeth Chachaty, Edwige Leclercq, Marie-Hélène Courtier, and Annelise Bennaceur-Griscelli, Institut Gustave Roussy; Jean-Baptiste Micol and Stéphane de Botton, Hématologie Clinique, Institut Gustave Roussy; Serge Koscielny, Service de Biostatistique et d'Epidémiologie, Institut Gustave Roussy, Villejuif; Elena Mylonas, Cyril Quivoron, Laurianne Scourzic, Olivier Adrien Bernard, Virginie Penard-Lacronique, Chris Ottolenghi, and Stéphane de Botton, Université Paris Sud-11, Orsay; Aline Renneville and Claude Preudhomme, Hématologie Biologique, Centre Hospitalier Régional Universitaire (CHRU) Lille; Céline Berthon, Hématologie Clinique, CHRU Lille, Lille; Cécile Pautas, Hématologie Clinique, Centre Hospitalier Henri Mondor, Créteil; and Denis Caillot, Hématologie Clinique, Centre Hospitalier Universitaire Dijon, Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.50.2047DOI Listing
February 2014

[Therapy-related acute myeloid leukemia: role of DNA repair].

Bull Cancer 2011 Mar;98(3):247-55

Université Clermont-I, Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2011.1325DOI Listing
March 2011

An activating mutation in the CSF3R gene induces a hereditary chronic neutrophilia.

J Exp Med 2009 Aug 20;206(8):1701-7. Epub 2009 Jul 20.

Research Laboratory on Hematopoiesis and Normal and Leukemic Stem Cells, U790, Institut National de la Santé et de la Recherche Médicale, 94805 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20090693DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722170PMC
August 2009

Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference.

J Mol Med (Berl) 2007 Oct 22;85(10):1069-76. Epub 2007 May 22.

Centre d'Investigation Clinique Biothérapie, Institut Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00109-007-0214-1DOI Listing
October 2007

Treatment of older adults with acute promyelocytic leukaemia.

Best Pract Res Clin Haematol 2003 Sep;16(3):495-501

Department of Hematology, Paris XIII University, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1521-6926(03)00044-6DOI Listing
September 2003

Platelet formation is the consequence of caspase activation within megakaryocytes.

Blood 2002 Aug;100(4):1310-7

Institut National de la Santé et de la Recherche Médicale U362 and the Centre National de la Recherche Scientifique (Unité Mixte de Recherche 1599), Institut Gustave Roussy, Institut Fédératif de Recherche 54, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2002-03-0686DOI Listing
August 2002

[Prognostic factors in myelodysplasia syndromes].

Pathol Biol (Paris) 2002 May;50(4):256-60

Service des Maladies du Sang, CHU de Lille, 1 place de Verdun, 59037 Lille.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0369-8114(02)00297-3DOI Listing
May 2002